1/4
Looks like no tags are added yet.
what was the study of the Toback et al Vaccine paper
is the nasal spray flu vaccine (LAIV) safe for children age 24-59 months? bc an earlier study found more wheezing in younger kids
What was the methodology of the Toback et al: Vaccine
followed 28,000 LAIV vax kids @ kaiser from 2007-2010
excluded kids w asthma or high risk conditions
compared them to three groups: unvax kids, kids w injected flu short (TIV), and same kids at diff. time windows after vax
counted medical attended events (diagnosis tied to a medical visit), serious adverse events, and hospitalizations
What were the results of the Toback et al: Vaccine
Asthma/wheezing was not increased and was actually lower in most comparisons
No deaths, and serious adverse events were similar across groups
Of 4,696 comparisons, 1.8% showed higher rates after LAIV and 4.7% showed lower rates. There was no pattern suggesting a safety problem
what were caveats in the Toback et al: Vaccine paper
With so many comparisons, some “significant” results happen by chance
The study was sponsored by MedImmune, the vaccine’s maker
groups weren’t random
What is the key point the Raff blog post “How to read vaccine safety study” is trying to show
people should read beyond the title and abstract before criticizing a study